Abstract
Over the few last decades, several additional urinary biomarkers have been correlated to other organ or system abnormalities other than kidney disease. In this setting, abnormal findings on a routine urinalysis, often in an otherwise asymptomatic patient, may be the first evidence of underlying kidney disease and even other diseases or conditions like a higher cardiovascular risk set.
A 24-h urine evaluation is still considered the gold standard method for the quantification of important urinary biomarkers like proteinuria. Nevertheless, its collection is laborious and entails significant errors that could compromise the accuracy of this method. Therefore, random spot urine assessment was developed to estimate quantitative measurements of 24-h collections. Many trials have been conducted to determine which formulae (correction for other parameters) and methods (including voiding of the day or technical procedures) are better to minimize sources of false results and enhance correlation with the gold standard. Currently, random spot urine examination is already mentioned in some international guidelines as an alternative analysis to diagnose and monitor several diseases. It allows the identification of multiple markers, which can be organized into three groups, according to their laboratory method assessment: physical, chemical, and microscopic characters. However, evidence regarding its role and power is still not unanimous, at least in some diseases, and future trials to prove how best to apply it are needed.
This review outlines random spot urine biomarkers for the kidney and their applications in clinical practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AKI:
-
Acute kidney injury
- ATN:
-
Acute tubular necrosis
- Ca:
-
Calcium
- CKD:
-
Chronic kidney disease
- CuSO4 :
-
Copper sulfate
- DBDH:
-
Diisopropylbenzene dihydroperoxide
- DIDNTB:
-
bis(3′,3″-Diiodo-4′,4″-dihydroxy-5′,5″-dinitrophenyl)-3,4,5,6-tetrabromo-sulfonephthalein
- eAER:
-
Estimated albumin excretion rate
- ESRD:
-
End-stage renal disease
- FCU:
-
Fractional renal clearance of urate
- GFR:
-
Glomerular filtration rate
- GN:
-
Glomerulonephritis
- INTERSALT:
-
International study of electrolyte excretion and blood pressure
- IRMA-2:
-
Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria
- K:
-
Potassium
- KDIGO:
-
Kidney Disease: Improving Global Outcomes
- LE:
-
Leukocyte esterase
- LN:
-
Lupus nephritis
- MESNA:
-
Mercaptoethane sulfonate sodium
- Mg:
-
Magnesium
- Na:
-
Sodium
- P/C:
-
Protein/creatinine ratio
- Ph:
-
Phosphate
- PREVEND:
-
Prevention of Renal and Vascular End-Stage Disease
- RBCs:
-
Red blood cells
- SG:
-
Specific gravity
- SGLT2:
-
Sodium/glucose cotransporter 2
- SLC5A2:
-
Solute carrier family 5
- SLE:
-
Systemic lupus erythematosus
- SNP:
-
Single-nucleotide polymorphisms
- SSA:
-
Sulfosalicylic acid
- STENO-2:
-
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
- TMB:
-
3,3′,5,5′-Tetramethylbenzidine
- UACR:
-
Urinary albumin/protein ratio
- UTI:
-
Urinary tract infection
- WBCs:
-
White blood cells
- Zn:
-
Zinc
References
Abdelmalek JA, Gansevoort RT, Lambers Heerspink HJ, et al. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the assessment of albuminuria: a diagnostic test study from the Prevention of Renal and Vascular Endstage Disease (PREVEND) Study. Am J Kidney Dis. 2014;63:415.
Antunes VVH, Veronese FJV, Morales JV. Diagnostic accuracy of the protein/creatinine ratio in urine samples to estimate 24-h proteinuria in patients with primary glomerulopathies: a longitudinal study. Nephrol Dial Transplant. 2008;23:2242–6.
Assadi FK, Fornell L. Estimation of urine specific gravity in neonates with a reagent strip. J Pediatr. 1986;108:995–6.
Ballarin J, Arce Y, Torra Balcells R, et al. Acute renal failure associated to paroxysmal nocturnal haemoglobinuria leads to intratubular haemosiderin accumulation and CD163 expression. Nephrol Dial Transplant. 2011;26:3408–11.
Barratt J, Topham P. Urine proteomics: the present and future of measuring urinary protein components in disease. CMAJ. 2007;177:361.
Bennett PH, Haffner S, Kasiske BL, et al. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis. 1995;25:107–12.
Birmingham DJ, Rovin BH, Shidham G, et al. Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int. 2007;72:865.
Brenner B, Taal M, Chertow G, et al. Brenner & Rector’s the kidney, 9th ed. Boston: Elsevier Health Sciences; 2011.
Brigden ML, Edgell D, McPherson M, et al. High incidence of significant urinary ascorbic acid concentrations in a west coast population – implications for routine urinalysis. Clin Chem. 1992;38:426.
Brodsky SV, Nadasdy T, Rovin BH, et al. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int. 2011;80:181–9.
Busby DE, Bakris GL. Comparison of commonly used assays for the detection of microalbuminuria. J Clin Hypertens (Greenwich). 2004;6:8.
Carter JL, Tomson CR, Stevens PE, et al. Does urinary tract infection cause proteinuria or microalbuminuria? A systematic review. Nephrol Dial Transplant. 2006;21:3031.
Cohen RA, Brown RS. Clinical practice. Microscopic hematuria. N Engl J Med. 2003;348:2330.
Comper WD, Osicka TM. Detection of urinary albumin. Adv Chron Kidney Dis. 2005;12:170.
Constantiner M, Sehgal AR, Humbert L, et al. A dipstick protein and specific gravity algorithm accurately predicts pathological proteinuria. Am J Kidney Dis. 2005;45:833.
Demilie T, Beyene G, Melaku S, et al. Diagnostic accuracy of rapid urine dipstick test to predict urinary tract infection among pregnant women in Felege Hiwot Referral Hospital, Bahir Dar. North West Ethiopia. BMC Res Notes. 2014;7:481.
Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care. 2000;23(12):1868–9.
Fassett RG, Horgan BA, Mathew TH. Detection of glomerular bleeding by phase-contrast microscopy. Lancet. 1982;1:1432–4.
Fine DM, Ziegenbein M, Petri M, et al. A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis. Kidney Int. 2009;76(12):1284–8.
Fogazzi GB. The urinary sediment: an integrated view. 3rd ed. Milan: Elsevier; 2010.
Fotheringham J, Campbell MJ, Fogarty DG, et al. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the estimation of measured albumin excretion rate: derivation and validation of an estimated albumin excretion rate equation. Am J Kidney Dis. 2014;63:405.
Garingalo-Molina FD. Asymptomatic bacteriuria among pregnant women: overview of diagnostic approaches. Phil J Microbiol Infect Dis. 2000;29:177–86.
Ginsberg JM, Chang BS, Matarese RA, et al. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983;309:1543.
Gökçe C, Gökçe O, Baydinç C, et al. Use of random urine samples to estimate total urinary calcium and phosphate excretion. Arch Intern Med. 1991;151(8):1587–8.
Gorchynski J, Dean K, Anderson CL. Analysis of urobilinogen and urine bilirubin for intra-abdominal injury in blunt trauma patients. West J Emerg Med. 2009;10(2):85–8.
Gray CH, Millar HR. Tests for glycosuria. A comparison of BenediCrS test, Clinitest and Glucotest. Br Med J. 1953; 1:1361–3.
Grossfeld G, Litwin M, Wolf J, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy – part I: definition, detection, prevalence and etiology. Urology. 2001;57:599–603.
Guedes-Marques M, Cotovio P, Ferrer F, et al. Random spot urine protein/creatinine ratio: a reliable method for monitoring lupus nephritis? Clin Kidney J. 2013;6:590–4.
Gutierrez E, Gonzalez E, Hernandez E, et al. Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy. Clin J Am Soc Nephrol. 2007;2:51–7.
Hahn B, Mcmahon M, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res. 2012;64(6):797–808.
Haque SK, Ariceta G, Batlle D. Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant. 2012;27:4273.
Heerspink HJL, Gansevoort RT, Brenner BM, et al. Comparison of different measures of urinary protein excretion for the prediction of renal events. J Am Soc Nephrol. 2010;21:1355–60.
Hemmelgarn BR, Zhang J, Manns BJ, et al. Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA. 2010;303:1151–8.
Hotta O, Yusa N, Kitamura H, et al. Urinary macrophages as activity markers of renal injury. Clin Chim Acta. 2000;297:123–33.
House AA, Cattran DC. Nephrology: 2. Evaluation of asymptomatic hematuria and proteinuria in adult primary care. CMAJ. 2002;166:348–53.
Ilich JZ, Blanusa M, Orlić ZC, et al. Comparison of calcium, magnesium, sodium, potassium, zinc, and creatinine concentration in 24-h and spot urine samples in women. Clin Chem Lab Med. 2009;47(2):216–21.
Iseki K. Proteinuria as a predictor of rapid eGFR decline. Nat Rev Nephrol. 2013;9:570–1.
Jacobs DS, De Mott WR, Willie GR. Urinalysis and clinical microscopy. In: Jacobs DS, Kasten BL, De Mott WR, Wolfson WL, editors. Laboratory test handbook. Baltimore: Williams & Wilkins; 1990. p. 912.
Ji C, Sykes L, Paul C, Dary O, et al. Systematic review of studies comparing 24-hour and spot urine collections for estimating population salt intake. Rev Panam Salud Publica. 2012;32(4):307–15.
Johnson R, Feehally J, Floege J. Comprehensive clinical nephrology, 5th ed. Philadelphia: Elsevier Health Sciences; 2014.
Jung K. Enzyme activities in urine: how should we express their excretion? A critical literature review. Eur J Clin Chem Clin Biochem. 1991;29:725–9.
Kannangara D, Ramasamy S, Indraratna S, et al. Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients. Arthritis Res Ther. 2012;14:R189. Kannangara et al002E.
KDIGO. Chapter 1: definition and classification of CKD. Kidney Int Suppl. 2013;3:19. http://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf. Accessed on Oct 2014.
Lam MO. False hematuria due to bacteriuria. Arch Pathol. 1995;119:717–21.
Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem. 2009;46:205–17.
Leung YY, Czeto CC, Tam LS, et al. Urine protein-to-creatinine ratio in an untimed urine collection is a reliable measure of proteinuria in lupus nephritis. Rheumatology (Oxford). 2007;46:649–52.
Lohr JA. Use of routine urinalysis in making a presumptive diagnosis of urinary tract infection in children. Pediatr Infect Dis J. 1991;10:646–50.
MacIsaac R, Ekinci E, Jerums G. Progressive diabetic nephropathy. How useful is microalbuminuria?: Contra. Kidney Int. 2014;86:50–7.
Magen D, Sprecher E, Zelikovic I, et al. A novel missense mutation in SLC5A2 encoding SGLT2 underlies autosomal-recessive renal glucosuria and aminoaciduria. Kidney Int. 2005;67:34–41.
Mann SJ, Gerber LM. Estimation of 24-hour sodium excretion from spot urine samples. J Clin Hypertens (Greenwich). 2010;12:174–80.
McCormack M, Dessureault J, Guitard M. The urine specific gravity dipstick: a useful tool to increase fluid intake in stone forming patients. J Urol. 1991;146:1475–7.
Methven S, MacGregor MS, Traynor JP, et al. Assessing proteinuria in chronic kidney disease: protein–creatinine ratio versus albumin–creatinine ratio. Nephrol Dial Transplant. 2010;25(9):2991–6.
Methven S, MacGregor MS, Traynor JP, Hair M, O’Reilly DJ, Deighan CJ. Comparison of urinary albumin and urinary total protein as predictors of patient outcomes in CKD. Am J Kidney Dis. 2011;57(1):21–8.
Mok CC, Tam SC, Kwong YL. Pseudonephrotic syndrome caused by lysozymuria. Ann Intern Med. 1994;121:818.
Morales JV, Weber R, Wagner MB, et al. Is morning urinary protein/creatinine ratio a reliable estimator of 24-hour proteinuria in patients with glomerulonephritis and different levels of renal function? J Nephrol. 2004;17(5):666–72.
Morcos SK, El-Nahas AM, Brown P, et al. Effect of iodinated water soluble contrast media on urinary protein assays. BMJ. 1992;305:29.
Moreno JA, Martı’n-Cleary C, Gutiérrez E. Editorial reviews haematuria: the forgotten CKD factor? Nephrol Dial Transplant. 2012;27:28–34.
Muto S, Sugiura S, Nakajima A, et al. Isomorphic red blood cells using automated urine flow cytometry is a reliable method in diagnosis of bladder cancer. Int J Clin Oncol. 2014;19(5):928–34.
Naresh CN, Hayen A, Craig JC, et al. Day-to-day variability in spot urine protein-creatinine ratio measurements. Am J Kidney Dis. 2012;60:561.
Nathan DM, Rosenbaum C, Protasowicki VD. Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care. 1987;10:414.
Newman DJ, Mattock MB, Dawnay BS, et al. Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess. 2005;9:30.
Nolan 3rd CR, Anger MS, Kelleher SP. Eosinophiluria – a new method of detection and definition of the clinical spectrum. N Engl J Med. 1986;315:1516.
Patel HD, Livsey SA, Swann RA, et al. Can urine dipstick testing for urinary tract infection at point of care reduce laboratory workload? J Clin Pathol. 2005;58:951–4.
Price CP, Newall R, Boyd JC. Use of protein/creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review. Clin Chem. 2005;51:1577–86.
Rahman MS, Beever W, Skov S, et al. Using urinary leucocyte esterase tests as an indicator of infection with gonorrhoea or chlamydia in asymptomatic males in a primary health care setting. Int J STD AIDS. 2014;25(2):138–44.
Rauta V, Finne P, Fagerudd J, et al. Factors associated with progression of IgA nephropathy are related to renal function – a model for estimating risk of progression in mild disease. Clin Nephrol. 2002;58:85–94.
Roscioni SS, Heerspink HJ, Zeeuw D. Microalbuminuria: target for renoprotective therapy PRO. Kidney Int. 2014;86:40–9.
Rose BD. Pathophysiology of renal disease. 2nd ed. New York: McGraw-Hill; 1987. p. 11.
Ruggenenti P, Remuzzi G. Time to abandon microalbuminuria? Kidney Int. 2006;70:1214–22.
Ruggenenti P, Porrini E, Motterlini N, et al. Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes. J Am Soc Nephrol. 2012;23:1717–24.
Sáez-Torres C, Rodrigo D, Grases F, et al. Urinary excretion of calcium, magnesium, phosphate, citrate, oxalate, and uric acid by healthy schoolchildren using a 12-h collection protocol. Pediatr Nephrol. 2014;29:1201–8.
Sand TE, Jacobsen S. Effect of urine pH and flow on renal clearance of methotrexate. Eur J Clin Pharmacol. 1981;19(6):453–6.
Saydah SH, Pavkov ME, Zhang C, et al. Albuminuria prevalence in first morning void compared with previous random urine from adults in the National Health and Nutrition Examination Survey, 2009–2010. Clin Chem. 2013;59(4):675–83.
Semeniuk H, Church D. Evaluation of the leukocyte esterase and nitrite urine dipstick screening tests for detection of bacteriuria in women with suspected uncomplicated urinary tract infections. J Clin Microbiol. 1999;37(9):3051–2.
Shidham G, Hebert LA. Timed urine collections are not needed to measure urine protein excretion in clinical practice. Am J Kidney Dis. 2006;47:8.
Siegrist D, Hess B, Montandon M, et al. Spezifi sches Gewicht des Urins-vergleichende Messungen mit Teststreifen und Refraktometer bei 340 Morgenurinproben. Schweiz Rundsch Med Prax. 1993;82:112–6.
Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am Fam Physician. 2005;71:1153.
Singer DE, Coley CM, Samet JH, et al. Tests of glycemia in diabetes mellitus: their use in establishing a diagnosis and in treatment. Ann Intern Med. 1989;110:125–37.
Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825.
Strasinger S, Di Lorenzo M. Urinalysis and body fluids, 6th ed. Philadelphia: F. A. Davis Company; 2014.
Sutton JM. Evaluation of hematuria in adults. JAMA. 1990;263:2475–80.
Taboulet P, Deconinck N, Thurel A, et al. Correlation between urine ketones (acetoacetate) and capillary blood ketones (3-beta-hydroxybutyrate) in hyperglycaemic patients. Diabetes Metab. 2007;33(2):135–9.
Tanaka T, Okamura T, Miura K, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16:97–103.
Tapp DC, Copley JB. Effect of red blood cell lysis on protein quantitation in hematuric states. Am J Nephrol. 1988;8:190.
Turin TC, James M, Ravani P, et al. Proteinuria and rate of change in kidney function in a community-based population. J Am Soc Nephrol. 2013;24(10):1661–7.
Vivante A, Afek A, Frenkel-Nir Y, et al. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA. 2011;306:729–36.
Wagner CA, Mohebbi N. Urinary pH and stone formation. J Nephrol. 2010;23(16):S165–9.
Wald R. Urinalysis in the diagnosis of kidney disease. In Uptodate. http://www.uptodate.com/contents/search. Accessed Oct 2014.
Wald R, Bell CM, Nisenbaum R, et al. Interobserver reliability of urine sediment interpretation. Clin J Am Soc Nephrol. 2009;4:567.
Wise KA, Sagert LA, Grammens GL. Urine leukocyte esterase and nitrite tests as an aid to predict urine culture results. Lab Med. 1984;15(3):186–7.
Witte EC, Lambers Heerspink HJ, de Zeeuw D, et al. First morning voids are more reliable than spot urine samples to assess microalbuminuria. J Am Soc Nephrol. 2009;20:436–43.
Woolhandler S, Pels RJ, Bor DH, Himmelstein DU, Lawrence RS. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria. JAMA. 1989;262:1214–9.
Young DS. Effects of drugs on clinical laboratory tests, vol. 3. 3rd ed. Washington, DC: American Association for Clinical Chemistry Press; 1990. p. 356–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Guedes-Marques, M., Botelho, C., Maia, P., Mendes, T., Carreira, A. (2016). Random Spot Urine Markers for Kidney and Their Applications. In: Patel, V., Preedy, V. (eds) Biomarkers in Kidney Disease. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7699-9_24
Download citation
DOI: https://doi.org/10.1007/978-94-007-7699-9_24
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7698-2
Online ISBN: 978-94-007-7699-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences